Rite Aid has ample opportunities to partner with health insurers and grow its EnvisionRx PBM into new Medicare Part D markets following the decision to end its merger with Albertsons.
CVS Health executives appear confident the acquisition of Aetna will survive antitrust scrutiny though there may be divestitures where the two sell overlapping Medicare drug coverage.
CVS Health said its retained share of rebates negotiated with drug makers this year comes to 2%, which translates to $300 million or 3% of the company’s annual earnings per share.
CVS Health’s MinuteClinic is launching a new “virtual health care offering” to allow patients round-the-clock treatment for minor illnesses, injuries and conditions from their mobile devices.